Dexcel Pharma USA Launches Nintedanib Capsules After FDA Approval#USA#Parsippany#Dexcel_Pharma#Nintedanib#OFEV
Dexcel Pharma USA Launches Nintedanib Capsules After FDA Approval
Dexcel Pharma USA has secured FDA approval for Nintedanib Capsules, a key treatment for Idiopathic Pulmonary Fibrosis. The launch marks an important step in expanding patient access to essential medications.
third-news.com
April 7, 2026 at 8:19 PM
Dexcel Pharma USA Launches Nintedanib Capsules After FDA Approval#USA#Parsippany#Dexcel_Pharma#Nintedanib#OFEV
Dexcel Pharma USA Secures U.S. Rights to Zubsolv® Expanding Treatment Options#USA#Parsippany,_NJ#Dexcel_Pharma#Zubsolv#Orexo_AB
Dexcel Pharma USA Secures U.S. Rights to Zubsolv® Expanding Treatment Options
Dexcel Pharma USA has announced the successful acquisition of U.S. rights for Zubsolv®, marking a significant step in their strategic growth in the U.S. market.
third-news.com
January 7, 2026 at 9:37 PM
Dexcel Pharma USA Secures U.S. Rights to Zubsolv® Expanding Treatment Options#USA#Parsippany,_NJ#Dexcel_Pharma#Zubsolv#Orexo_AB